Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
12,569
Total Claims
$434K
Drug Cost
808
Beneficiaries
$537
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 7,389 General Practice providers
-88%
Opioid rate vs peers
0.3% vs 2.5% avg
-52%
Cost per patient vs peers
$537 vs $1,128 avg
+7%
Brand preference vs peers
9.0% vs 8.4% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
0.3%
Opioid Rate
38
Opioid Claims
$124
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,109 claims · $294K
Generic: 11,183 claims · $134K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 80 | $50K |
| Insulin Glargine,hum.Rec.Anlog | 75 | $34K |
| Linagliptin | 40 | $22K |
| Insulin Nph Human Isophane | 55 | $22K |
| Levothyroxine Sodium | 324 | $20K |
| Dapagliflozin Propanediol | 26 | $16K |
| Rivaroxaban | 27 | $15K |
| Sitagliptin Phos/Metformin Hcl | 17 | $11K |
| Insulin Nph Hum/Reg Insulin Hm | 45 | $11K |
| Insulin Glargine-Yfgn | 56 | $7,269 |
| Empagliflozin/Metformin Hcl | 11 | $6,645 |
| Insulin Glargine,hum.Rec.Anlog | 17 | $6,136 |
| Atorvastatin Calcium | 446 | $5,872 |
| Irbesartan/Hydrochlorothiazide | 160 | $5,624 |
| Gabapentin | 1,043 | $5,592 |
Prescribing Profile
Patient Profile
70
Avg Age
59%
Female
1.97
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data